The Role of G Protein-Coupled Receptors (GPCRs) and Calcium Signaling in Schizophrenia. Focus on GPCRs Activated by Neurotransmitters and Chemokines
出版年份 2021 全文链接
标题
The Role of G Protein-Coupled Receptors (GPCRs) and Calcium Signaling in Schizophrenia. Focus on GPCRs Activated by Neurotransmitters and Chemokines
作者
关键词
-
出版物
Cells
Volume 10, Issue 5, Pages 1228
出版商
MDPI AG
发表日期
2021-05-18
DOI
10.3390/cells10051228
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Increasing Nrf2 Activity as a Treatment Approach in Neuropsychiatry
- (2021) G. Morris et al. MOLECULAR NEUROBIOLOGY
- Oxidative Stress-Related Mechanisms in Schizophrenia Pathogenesis and New Treatment Perspectives
- (2021) Evgeny A. Ermakov et al. Oxidative Medicine and Cellular Longevity
- Effect of 5-HT2A receptor antagonism on levels of D2/3 receptor occupancy and adverse behavioral side-effects induced by haloperidol: a SPECT imaging study in the rat
- (2021) Stergios Tsartsalis et al. Translational Psychiatry
- Increased random exploration in schizophrenia is associated with inflammation
- (2021) Flurin Cathomas et al. npj Schizophrenia
- Noradrenergic suppression of persistent firing in hippocampal CA1 pyramidal cells through cAMP-PKA pathway
- (2021) Maria Jesus Valero-Aracama et al. eNeuro
- Binding of clozapine to the GABAB receptor: clinical and structural insights
- (2020) Pramod C. Nair et al. MOLECULAR PSYCHIATRY
- Norepinephrine, neurodevelopment and behavior
- (2020) Ehsan Saboory et al. NEUROCHEMISTRY INTERNATIONAL
- Diminished levels of the chemokine fractalkine in post-mortem prefrontal cortex in schizophrenia but not bipolar disorder
- (2020) Sarah L. Hill et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Elevated serum chemokine CCL22 levels in first-episode psychosis: associations with symptoms, peripheral immune state and in vivo brain glial cell function
- (2020) Heikki Laurikainen et al. Translational Psychiatry
- Preliminary Efficacy and Tolerability Profiles of First versus Second-Generation Long-Acting Injectable Antipsychotics in Schizophrenia: A Systematic Review and Meta-Analysis
- (2020) Erasmo Saucedo Uribe et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Functional impairment of cortical AMPA receptors in schizophrenia
- (2020) Tommaso Zeppillo et al. SCHIZOPHRENIA RESEARCH
- Maternal Immune Activation Sensitizes Male Offspring Rats to Lipopolysaccharide-Induced Microglial Deficits Involving the Dysfunction of CD200–CD200R and CX3CL1–CX3CR1 Systems
- (2020) Katarzyna Chamera et al. Cells
- NFATc2-dependent epigenetic upregulation of CXCL14 is involved in the development of neuropathic pain induced by paclitaxel
- (2020) Meng Liu et al. Journal of Neuroinflammation
- A Review of Molecular Imaging of Glutamate Receptors
- (2020) Jong-Hoon Kim et al. MOLECULES
- High Mobility Group Protein 1 and Dickkopf-Related Protein 1 in Schizophrenia and Treatment-Resistant Schizophrenia: Associations With Interleukin-6, Symptom Domains, and Neurocognitive Impairments
- (2020) Arafat Hussein Al-Dujaili et al. SCHIZOPHRENIA BULLETIN
- The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders
- (2020) Paulina Pawelec et al. Cells
- The Role of Microglial CX3CR1 in Schizophrenia-Related Behaviors Induced by Social Isolation
- (2020) Hao Zhou et al. Frontiers in Integrative Neuroscience
- Regulation of Reactive Oxygen Species-Mediated Damage in the Pathogenesis of Schizophrenia
- (2020) Samskruthi Madireddy et al. Brain Sciences
- CCL-11 or Eotaxin-1: An Immune Marker for Ageing and Accelerated Ageing in Neuro-Psychiatric Disorders
- (2020) Mariya Ivanovska et al. Pharmaceuticals
- Biased signaling in naturally occurring mutations of G protein-coupled receptors associated with diverse human diseases
- (2020) Li-Kun Yang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Differential Effects of Acute Treatment With Antipsychotic Drugs on Peripheral Catecholamines
- (2020) Heidi N. Boyda et al. Frontiers in Psychiatry
- Biased agonism at chemokine receptors
- (2020) Dylan Scott Eiger et al. CELLULAR SIGNALLING
- Increased peripheral levels of TARC/CCL17 in first episode psychosis patients
- (2019) Anna Malmqvist et al. SCHIZOPHRENIA RESEARCH
- Role of Metabotropic Glutamate Receptors in Neurological Disorders
- (2019) Rosalia Crupi et al. Frontiers in Molecular Neuroscience
- Design of novel dopamine D2 and serotonin 5-HT2A receptors dual antagonists toward schizophrenia: An integrated study with QSAR, molecular docking, virtual screening and molecular dynamics simulations
- (2019) Cuihua Zhang et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- M1 muscarinic receptors regulate the phosphorylation of AMPA receptor subunit GluA1 via a signaling pathway linking cAMP-PKA and PI3K-Akt
- (2019) Lan-Xue Zhao et al. FASEB JOURNAL
- Serotonin and Glutamate Interactions in Preclinical Schizophrenia Models
- (2019) Urjita H. Shah et al. ACS Chemical Neuroscience
- Potential Utility of Biased GPCR Signaling for Treatment of Psychiatric Disorders
- (2019) Hidetoshi Komatsu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Advances in Dopamine D1 Receptor Ligands for Neurotherapeutics
- (2019) Daniel E. Felsing et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Cholinergic muscarinic M1 and M4 receptors as therapeutic targets for cognitive, behavioural, and psychological symptoms in psychiatric and neurological disorders
- (2019) Daniel Erskine et al. DRUG DISCOVERY TODAY
- The Role of the CXCL12/CXCR4/ACKR3 Axis in Autoimmune Diseases
- (2019) Eva M. García-Cuesta et al. Frontiers in Endocrinology
- The Potential Role of Dysfunctions in Neuron – Microglia Communication in the Pathogenesis of Brain Disorders.
- (2019) Katarzyna Chamera et al. Current Neuropharmacology
- An evaluation of lumateperone tosylate for the treatment of schizophrenia
- (2019) Pankhuri Vyas et al. EXPERT OPINION ON PHARMACOTHERAPY
- Functional coupling of M1 muscarinic acetylcholine receptor to Gαq/11 in dorsolateral prefrontal cortex from patients with psychiatric disorders: a postmortem study
- (2019) Yuji Odagaki et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Calmodulin as a protein linker and a regulator of adaptor/scaffold proteins
- (2018) Antonio Villalobo et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Profiling inflammatory signatures of schizophrenia: A cross-sectional and meta-analysis study
- (2018) Dorota Frydecka et al. BRAIN BEHAVIOR AND IMMUNITY
- Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis
- (2018) Marc Krause et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- M1 muscarinic receptor facilitates cognitive function by interplay with AMPA receptor GluA1 subunit
- (2018) Lan-Xue Zhao et al. FASEB JOURNAL
- A guide to chemokines and their receptors
- (2018) Catherine E. Hughes et al. FEBS Journal
- Glutamatergic Signaling in the Central Nervous System: Ionotropic and Metabotropic Receptors in Concert
- (2018) Andreas Reiner et al. NEURON
- Regulation of neural ion channels by muscarinic receptors
- (2018) David A. Brown NEUROPHARMACOLOGY
- Cloning, Expression, Purification and Characterization of Oligomeric States of the Native 5HT2A G-Protein-Coupled Receptor
- (2018) Gopa Mahesh et al. PROTEIN AND PEPTIDE LETTERS
- Efficacy and safety of brexpiprazole for the treatment of acute schizophrenia in Japan: A 6-week, randomized, double-blind, placebo-controlled study
- (2018) Jun Ishigooka et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Global Epidemiology and Burden of Schizophrenia: Findings From the Global Burden of Disease Study 2016
- (2018) Fiona J Charlson et al. SCHIZOPHRENIA BULLETIN
- Lack of beta-arrestin signaling in the absence of active G proteins
- (2018) Manuel Grundmann et al. Nature Communications
- Relationship between muscarinic M 1 receptor binding and cognition in medication-free subjects with psychosis
- (2018) Geor Bakker et al. NeuroImage-Clinical
- Current Concepts and Treatments of Schizophrenia
- (2018) Piotr Stępnicki et al. MOLECULES
- Eotaxin, an Endogenous Cognitive Deteriorating Chemokine (ECDC), Is a Major Contributor to Cognitive Decline in Normal People and to Executive, Memory, and Sustained Attention Deficits, Formal Thought Disorders, and Psychopathology in Schizophrenia Patients
- (2018) Sunee Sirivichayakul et al. NEUROTOXICITY RESEARCH
- Glioma in Schizophrenia: Is the Risk Higher or Lower?
- (2018) Xingchun Gao et al. Frontiers in Cellular Neuroscience
- Negative Allosteric Modulators of mGlu7 Receptor as Putative Antipsychotic Drugs
- (2018) Paulina Cieślik et al. Frontiers in Molecular Neuroscience
- Blood-Brain Barrier: From Physiology to Disease and Back
- (2018) Melanie D. Sweeney et al. PHYSIOLOGICAL REVIEWS
- Group II Metabotropic Glutamate Receptors: Role in Pain Mechanisms and Pain Modulation
- (2018) Mariacristina Mazzitelli et al. Frontiers in Molecular Neuroscience
- Revisiting the Concept of Targeting NFAT to Control T Cell Immunity and Autoimmune Diseases
- (2018) Jae-Ung Lee et al. Frontiers in Immunology
- The high efficacy of muscarinic M4 receptor in D1 medium spiny neurons reverses striatal hyperdopaminergia
- (2018) Anu G. Nair et al. NEUROPHARMACOLOGY
- Mechanisms of Regulation of the Chemokine-Receptor Network
- (2017) Martin Stone et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder
- (2017) Danny Boerrigter et al. Journal of Neuroinflammation
- Neurochemical and behavioral studies on the 5-HT 1A -dependent antipsychotic action of the mGlu 4 receptor agonist LSP4-2022
- (2017) Monika Woźniak et al. NEUROPHARMACOLOGY
- Oxidative and nitrosative stress biomarkers in chronic schizophrenia
- (2017) Karine Maria Boll et al. PSYCHIATRY RESEARCH
- Effects of GABA-B receptor positive modulator on ketamine-induced psychosis-relevant behaviors and hippocampal electrical activity in freely moving rats
- (2017) Jingyi Ma et al. PSYCHOPHARMACOLOGY
- 30 Years on: How the Neurodevelopmental Hypothesis of Schizophrenia Morphed Into the Developmental Risk Factor Model of Psychosis
- (2017) Robin M Murray et al. SCHIZOPHRENIA BULLETIN
- Abnormalities in chemokine levels in schizophrenia and their clinical correlates
- (2017) Suzi Hong et al. SCHIZOPHRENIA RESEARCH
- An emerging role for mitochondrial dynamics in schizophrenia
- (2017) Kyle H. Flippo et al. SCHIZOPHRENIA RESEARCH
- Genetic evidence that β-arrestins are dispensable for the initiation of β2-adrenergic receptor signaling to ERK
- (2017) Morgan O’Hayre et al. Science Signaling
- GABAA and GABAB receptor dysregulation in superior frontal cortex of subjects with schizophrenia and bipolar disorder
- (2017) S. Hossein Fatemi et al. SYNAPSE
- Targeting metabotropic glutamate receptors for novel treatments of schizophrenia
- (2017) James Maksymetz et al. Molecular Brain
- The role of microglia and their CX3CR1 signaling in adult neurogenesis in the olfactory bulb
- (2017) Ronen Reshef et al. eLife
- Genetic evidence that β-arrestins are dispensable for the initiation of β2-adrenergic receptor signaling to ERK
- (2017) Morgan O’Hayre et al. Science Signaling
- Rare genetic variants in CX3CR1 and their contribution to the increased risk of schizophrenia and autism spectrum disorders
- (2017) K Ishizuka et al. Translational Psychiatry
- IL1R2, CCR2, and CXCR4 May Form Heteroreceptor Complexes with NMDAR and D2R: Relevance for Schizophrenia
- (2017) Dasiel O. Borroto-Escuela et al. Frontiers in Psychiatry
- Neurovascular Unit Dysfunction and Blood–Brain Barrier Hyperpermeability Contribute to Schizophrenia Neurobiology: A Theoretical Integration of Clinical and Experimental Evidence
- (2017) Souhel Najjar et al. Frontiers in Psychiatry
- Serotonin receptors in brain revisited
- (2016) José M. Palacios BRAIN RESEARCH
- The Role of mGlu Receptors in Hippocampal Plasticity Deficits in Neurological and Psychiatric Disorders: Implications for Allosteric Modulators as Novel Therapeutic Strategies
- (2016) Rebecca K. Senter et al. Current Neuropharmacology
- Serotonergic and Cholinergic Strategies as Potential Targets for the Treatment of Schizophrenia
- (2016) Agnieszka Nikiforuk CURRENT PHARMACEUTICAL DESIGN
- Low frontal serotonin 2A receptor binding is a state marker for schizophrenia?
- (2016) Hans Rasmussen et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- An mGlu5-Positive Allosteric Modulator Rescues the Neuroplasticity Deficits in a Genetic Model of NMDA Receptor Hypofunction in Schizophrenia
- (2016) Darrick T Balu et al. NEUROPSYCHOPHARMACOLOGY
- Sex/gender differences in the brain and cognition in schizophrenia
- (2016) Adrianna Mendrek et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Gβγ subunits—Different spaces, different faces
- (2016) Shahriar M. Khan et al. PHARMACOLOGICAL RESEARCH
- AZD8529, a positive allosteric modulator at the mGluR2 receptor, does not improve symptoms in schizophrenia: A proof of principle study
- (2016) Robert E. Litman et al. SCHIZOPHRENIA RESEARCH
- Allosteric signaling through an mGlu2 and 5-HT2Aheteromeric receptor complex and its potential contribution to schizophrenia
- (2016) José L. Moreno et al. Science Signaling
- Reduced Prepulse Inhibition as a Biomarker of Schizophrenia
- (2016) Auxiliadora Mena et al. Frontiers in Behavioral Neuroscience
- Allosteric signaling through an mGlu2 and 5-HT2Aheteromeric receptor complex and its potential contribution to schizophrenia
- (2016) José L. Moreno et al. Science Signaling
- Atypical Chemokine Receptors and Their Roles in the Resolution of the Inflammatory Response
- (2016) Raffaella Bonecchi et al. Frontiers in Immunology
- Increased GABAB receptor signaling in a rat model for schizophrenia
- (2016) Martijn M. Selten et al. Scientific Reports
- Stress Impairs Prefrontal Cortical Function via D1 Dopamine Receptor Interactions With Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels
- (2015) Nao J. Gamo et al. BIOLOGICAL PSYCHIATRY
- NFAT-1, Sp-1, Sp-3, and miR-21: New regulators of chemokine C receptor 7 expression in mature human dendritic cells
- (2015) Carine Al Akoum et al. HUMAN IMMUNOLOGY
- Pharmacokinetic and pharmacodynamic characterisation of JNJ-40411813, a positive allosteric modulator of mGluR2, in two randomised, double-blind phase-I studies
- (2015) Hiba Salih et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Potentiation of M1 Muscarinic Receptor Reverses Plasticity Deficits and Negative and Cognitive Symptoms in a Schizophrenia Mouse Model
- (2015) A Ghoshal et al. NEUROPSYCHOPHARMACOLOGY
- Mitochondrial dysfunction in schizophrenia: Pathways, mechanisms and implications
- (2015) Ashwini Rajasekaran et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Inflammatory Markers in Recent Onset Psychosis and Chronic Schizophrenia
- (2015) Faith Dickerson et al. SCHIZOPHRENIA BULLETIN
- Systematic Review of the Neurobiological Relevance of Chemokines to Psychiatric Disorders
- (2015) Michael J. Stuart et al. Frontiers in Cellular Neuroscience
- A potential interaction between COMT and MTHFR genetic variants in Han Chinese patients with bipolar II disorder
- (2015) Liang-Jen Wang et al. Scientific Reports
- Role of nitric oxide and related molecules in schizophrenia pathogenesis: biochemical, genetic and clinical aspects
- (2015) Regina F. Nasyrova et al. Frontiers in Physiology
- Oxidative stress in schizophrenia: a case-control study on the effects on social cognition and neurocognition
- (2014) Cristina Gonzalez-Liencres et al. BMC Psychiatry
- The Glutamatergic Aspects of Schizophrenia Molecular Pathophysiology: Role of the Postsynaptic Density, and Implications for Treatment
- (2014) Felice Iasevoli et al. Current Neuropharmacology
- New nomenclature for atypical chemokine receptors
- (2014) Françoise Bachelerie et al. NATURE IMMUNOLOGY
- Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: A systematic review of biomarker studies
- (2014) M.J. Stuart et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Alterations in the serotonin system in schizophrenia: A systematic review and meta-analysis of postmortem and molecular imaging studies
- (2014) Sudhakar Selvaraj et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Effects of co-administration of the GABAB receptor agonist baclofen and a positive allosteric modulator of the GABAB receptor, CGP7930, on the development and expression of amphetamineinduced locomotor sensitization in rats
- (2014) Laura N. Cedillo et al. Pharmacological Reports
- Biperiden selectively induces memory impairment in healthy volunteers: no interaction with citalopram
- (2014) Anke Sambeth et al. PSYCHOPHARMACOLOGY
- Differences in eotaxin serum levels patients with recent onset and in chronic stable schizophrenia: A clue for understanding accelerating aging profile
- (2014) Mariana Pedrini et al. SCHIZOPHRENIA RESEARCH
- Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder
- (2014) S G Fillman et al. Translational Psychiatry
- Is There a Path Forward for mGlu2 Positive Allosteric Modulators for the Treatment of Schizophrenia?
- (2013) Corey R. Hopkins ACS Chemical Neuroscience
- Meta-Analysis of Oxidative Stress in Schizophrenia
- (2013) Joshua Flatow et al. BIOLOGICAL PSYCHIATRY
- A long-term, phase 2, multicenter, randomized, open-label, comparative safety study of pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of care in patients with schizophrenia
- (2013) David H Adams et al. BMC Psychiatry
- The antipsychotic-like effects of positive allosteric modulators of metabotropic glutamate mGlu4receptors in rodents
- (2013) Anna Sławińska et al. BRITISH JOURNAL OF PHARMACOLOGY
- Emerging roles of store-operated Ca2+entry through STIM and ORAI proteins in immunity, hemostasis and cancer
- (2013) Wolfgang Bergmeier et al. Channels
- Schizophrenia and dopamine receptors
- (2013) Philip Seeman EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Is the mTOR-signalling cascade disrupted in Schizophrenia?
- (2013) Anand Gururajan et al. JOURNAL OF NEUROCHEMISTRY
- Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia
- (2013) Elson Asevedo et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Activation of 2-adrenoceptor enhances synaptic potentiation and behavioral memory via cAMP-PKA signaling in the medial prefrontal cortex of rats
- (2013) H.-C. Zhou et al. LEARNING & MEMORY
- Markers of inflammation in the prefrontal cortex of individuals with schizophrenia
- (2013) S G Fillman et al. MOLECULAR PSYCHIATRY
- Related functions of mGlu4 and mGlu8
- (2013) Matthew J. Davis et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Current status of chemokines in the adult CNS
- (2013) Annabelle Réaux-Le Goazigo et al. PROGRESS IN NEUROBIOLOGY
- The antipsychotic-like effects of the mGlu group III orthosteric agonist, LSP1-2111, involves 5-HT1A signalling
- (2013) Joanna M. Wierońska et al. PSYCHOPHARMACOLOGY
- Clonidine Normalizes Levels of P50 Gating in Patients With Schizophrenia on Stable Medication
- (2013) Bob Oranje et al. SCHIZOPHRENIA BULLETIN
- Cholinergic connectivity: it's implications for psychiatric disorders
- (2013) Elizabeth Scarr et al. Frontiers in Cellular Neuroscience
- Nitric Oxide and Schizophrenia: Present Knowledge and Emerging Concepts of Therapy
- (2012) Hans-Gert Bernstein et al. CNS & Neurological Disorders-Drug Targets
- Widespread decreases in cortical muscarinic receptors in a subset of people with schizophrenia
- (2012) Andrew Stuart Gibbons et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Norepinephrine: A Neuromodulator That Boosts the Function of Multiple Cell Types to Optimize CNS Performance
- (2012) John O’Donnell et al. NEUROCHEMICAL RESEARCH
- Acetylcholine as a Neuromodulator: Cholinergic Signaling Shapes Nervous System Function and Behavior
- (2012) Marina R. Picciotto et al. NEURON
- Clinical development of pomaglumetad methionil: A non-dopaminergic treatment for schizophrenia
- (2012) Bruce J. Kinon et al. NEUROPHARMACOLOGY
- Clozapine-Induced Locomotor Suppression is Mediated by 5-HT2A Receptors in the Forebrain
- (2012) Caitlin E McOmish et al. NEUROPSYCHOPHARMACOLOGY
- Deleterious GRM1 Mutations in Schizophrenia
- (2012) Mohammed Akli Ayoub et al. PLoS One
- The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia
- (2012) Kyoung-Sae Na et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Clonidine Normalizes Sensorimotor Gating Deficits in Patients With Schizophrenia on Stable Medication
- (2012) Bob Oranje et al. SCHIZOPHRENIA BULLETIN
- Effects of 5-HT2A and 5-HT2C receptor antagonists on acute and chronic dyskinetic effects induced by haloperidol in rats
- (2011) Meaghan Creed-Carson et al. BEHAVIOURAL BRAIN RESEARCH
- The GABABreceptor agonist CGP44532 and the positive modulator GS39783 reverse some behavioural changes related to positive syndromes of psychosis in mice
- (2011) JM Wierońska et al. BRITISH JOURNAL OF PHARMACOLOGY
- Neurodevelopmental hypothesis of schizophrenia
- (2011) Michael J. Owen et al. BRITISH JOURNAL OF PSYCHIATRY
- Regulation of β-adrenergic receptor function
- (2011) Neelakantan T. Vasudevan et al. CELL CYCLE
- Dopamine Receptor Interacting Proteins: Targeting Neuronal Calcium Sensor-1/D2 Dopamine Receptor Interaction for Antipsychotic Drug Development
- (2011) Nadine Kabbani et al. CURRENT DRUG TARGETS
- Mechanisms regulating chemokine receptor activity
- (2011) Laura D. Bennett et al. IMMUNOLOGY
- Duloxetine as adjunctive treatment to clozapine in patients with schizophrenia
- (2011) Umberto Mico’ et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Neurochemokines: a menage a trois providing new insights on the functions of chemokines in the central nervous system
- (2011) William Rostène et al. JOURNAL OF NEUROCHEMISTRY
- Neuronal basis of age-related working memory decline
- (2011) Min Wang et al. NATURE
- Selective Blockade of Dopamine D3 Receptors Enhances while D2 Receptor Antagonism Impairs Social Novelty Discrimination and Novel Object Recognition in Rats: A Key Role for the Prefrontal Cortex
- (2011) David JG Watson et al. NEUROPSYCHOPHARMACOLOGY
- Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists
- (2011) José L. Moreno et al. NEUROSCIENCE LETTERS
- D2 receptor overexpression in the striatum leads to a deficit in inhibitory transmission and dopamine sensitivity in mouse prefrontal cortex
- (2011) Y.-C. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- GABAB receptor blockade in the hippocampus affects sensory and sensorimotor gating in Long-Evans rats
- (2011) Jingyi Ma et al. PSYCHOPHARMACOLOGY
- Mutual independence of 5-HT2 and α1 noradrenergic receptors in mediating deficits in sensorimotor gating
- (2011) Sarah K. Baisley et al. PSYCHOPHARMACOLOGY
- Deficits in GABAB receptor system in schizophrenia and mood disorders: A postmortem study
- (2011) S. Hossein Fatemi et al. SCHIZOPHRENIA RESEARCH
- Alterations in Metabotropic Glutamate Receptor 1α and Regulator of G Protein Signaling 4 in the Prefrontal Cortex in Schizophrenia
- (2010) David W. Volk et al. AMERICAN JOURNAL OF PSYCHIATRY
- Metabotropic Glutamate Receptors: Physiology, Pharmacology, and Disease
- (2010) Colleen M. Niswender et al. Annual Review of Pharmacology and Toxicology
- Acetylcholinesterase Inhibitors (AChEI's) for the treatment of visual hallucinations in schizophrenia: a case report
- (2010) Sachin S Patel et al. BMC Psychiatry
- Metabotropic glutamate receptor 7: At the interface of cognition and emotion
- (2010) Richard M. O'Connor et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Chemokines and chemokine receptors: New actors in neuroendocrine regulations
- (2010) William Rostène et al. FRONTIERS IN NEUROENDOCRINOLOGY
- More evidence on additive antipsychotic effect of adjunctive mirtazapine in schizophrenia: an extension phase of a randomized controlled trial
- (2010) Viacheslav Terevnikov et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- A Subpopulation of Neuronal M4 Muscarinic Acetylcholine Receptors Plays a Critical Role in Modulating Dopamine-Dependent Behaviors
- (2010) J. Jeon et al. JOURNAL OF NEUROSCIENCE
- Decreased binding of [11C]NNC112 and [11C]SCH23390 in patients with chronic schizophrenia
- (2010) Jun Kosaka et al. LIFE SCIENCES
- Teaching old receptors new tricks: biasing seven-transmembrane receptors
- (2010) Sudarshan Rajagopal et al. NATURE REVIEWS DRUG DISCOVERY
- GABAB Receptors Modulate NMDA Receptor Calcium Signals in Dendritic Spines
- (2010) Jason R. Chalifoux et al. NEURON
- M1 Muscarinic Receptors Boost Synaptic Potentials and Calcium Influx in Dendritic Spines by Inhibiting Postsynaptic SK Channels
- (2010) Andrew J. Giessel et al. NEURON
- Facilitation of Long-Term Potentiation by Muscarinic M1 Receptors Is Mediated by Inhibition of SK Channels
- (2010) Katherine A. Buchanan et al. NEURON
- The validity of scopolamine as a pharmacological model for cognitive impairment: A review of animal behavioral studies
- (2010) Inge Klinkenberg et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Oxidative stress in schizophrenia: An integrated approach
- (2010) Byron K.Y. Bitanihirwe et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Beta-Blocker Supplementation of Standard Drug Treatment for Schizophrenia
- (2010) E. Shek et al. SCHIZOPHRENIA BULLETIN
- Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8
- (2010) Lauren M. Ellman et al. SCHIZOPHRENIA RESEARCH
- The Expanded Biology of Serotonin
- (2009) Miles Berger et al. Annual Review of Medicine
- Cholinergic receptor pathways involved in apoptosis, cell proliferation and neuronal differentiation
- (2009) Rodrigo R Resende et al. Cell Communication and Signaling
- Group II metabotropic glutamate receptors and schizophrenia
- (2009) José L. Moreno et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- GABAB Receptors, Schizophrenia and Sleep Dysfunction
- (2009) Joshua Kantrowitz et al. CNS DRUGS
- The effect of mGlu8deficiency in animal models of psychiatric diseases
- (2009) M. Fendt et al. GENES BRAIN AND BEHAVIOR
- The muscarinic M1 receptor activates Nrf2 through a signaling cascade that involves protein kinase C and inhibition of GSK-3beta: connecting neurotransmission with neuroprotection
- (2009) Sandra Espada et al. JOURNAL OF NEUROCHEMISTRY
- ADHD and the Prefrontal Cortex
- (2009) Amy F.T. Arnsten JOURNAL OF PEDIATRICS
- AC-260584, an orally bioavailable M1 muscarinic receptor allosteric agonist, improves cognitive performance in an animal model
- (2009) Stefania Risso Bradley et al. NEUROPHARMACOLOGY
- Prefrontal GABAB Receptor Activation Attenuates Phencyclidine-Induced Impairments of Prepulse Inhibition: Involvement of Nitric Oxide
- (2009) Kim Fejgin et al. NEUROPSYCHOPHARMACOLOGY
- Combined administration of an mGlu2/3 receptor agonist and a 5-HT2A receptor antagonist markedly attenuate the psychomotor-activating and neurochemical effects of psychostimulants
- (2009) Jason M. Uslaner et al. PSYCHOPHARMACOLOGY
- The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: A double-blind randomized placebo-controlled trial
- (2009) Seyed-Hesameddin Abbasi et al. SCHIZOPHRENIA RESEARCH
- The β1-adrenergic receptor mediates extracellular signal-regulated kinase activation via Gαs
- (2008) Junfang Zheng et al. AMINO ACIDS
- Scavenging roles of chemokine receptors: chemokine receptor deficiency is associated with increased levels of ligand in circulation and tissues
- (2008) A. E. Cardona et al. BLOOD
- Cholinergic-Mediated IP3-Receptor Activation Induces Long-Lasting Synaptic Enhancement in CA1 Pyramidal Neurons
- (2008) D. F. de Sevilla et al. JOURNAL OF NEUROSCIENCE
- Differential Contributions of Prefrontal and Hippocampal Dopamine D1 and D2 Receptors in Human Cognitive Functions
- (2008) H. Takahashi et al. JOURNAL OF NEUROSCIENCE
- Large recurrent microdeletions associated with schizophrenia
- (2008) Hreinn Stefansson et al. NATURE
- Identification of a serotonin/glutamate receptor complex implicated in psychosis
- (2008) Javier González-Maeso et al. NATURE
- Postsynaptic α-2 Adrenergic Receptors are Critical for the Antidepressant-Like Effects of Desipramine on Behavior
- (2008) Han-Ting Zhang et al. NEUROPSYCHOPHARMACOLOGY
- Involvement of Pallidotegmental Neurons in Methamphetamine- and MK-801-Induced Impairment of Prepulse Inhibition of the Acoustic Startle Reflex in Mice: Reversal by GABAB Receptor Agonist Baclofen
- (2008) Sawako Arai et al. NEUROPSYCHOPHARMACOLOGY
- High-dose galantamine augmentation inferior to placebo on attention, inhibitory control and working memory performance in nonsmokers with schizophrenia
- (2008) M DYER et al. SCHIZOPHRENIA RESEARCH
- Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia
- (2008) John E. Lisman et al. TRENDS IN NEUROSCIENCES
- Serotonin research: contributions to understanding psychoses
- (2008) M GEYER et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Galantamine for the Treatment of Cognitive Impairments in People With Schizophrenia
- (2007) Robert W. Buchanan et al. AMERICAN JOURNAL OF PSYCHIATRY
- Activation of the nuclear factor of activated T-cells (NFAT) mediates upregulation of CCR2 chemokine receptors in dorsal root ganglion (DRG) neurons: A possible mechanism for activity-dependent transcription in DRG neurons in association with neuropathic pain
- (2007) Hosung Jung et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Increased serum levels of CCL11/eotaxin in schizophrenia
- (2007) Antonio Lucio Teixeira et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Neuropharmacology of 5-hydroxytryptamine
- (2006) A Richard Green BRITISH JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started